Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Verzenio (abemaciclib)
pCPA File Number:
21141
Negotiation Status:
Concluded without agreement
Indication(s):
Advanced or Metastatic Breast Cancer
Sponsor/Manufacturer:
Eli Lilly Canada Inc.
CADTH Project Number:
pCODR 10161
pCPA Engagement Letter Issued:
2019-09-30
Negotiation Process Concluded:
2020-04-09